Parkwood LLC Buys 5,535 Shares of Monsanto Company (NYSE:MON)
Parkwood LLC increased its position in shares of Monsanto Company (NYSE:MON) by 90.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,665 shares of the basic materials company’s stock after buying an additional 5,535 shares during the period. Parkwood LLC’s holdings in Monsanto were worth $1,381,000 as of its most recent filing with the SEC.
Several other large investors also recently added to or reduced their stakes in the stock. BlackRock Inc. raised its stake in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock worth $2,965,029,000 after buying an additional 25,140,936 shares during the period. York Capital Management Global Advisors LLC raised its stake in Monsanto by 58.4% in the first quarter. York Capital Management Global Advisors LLC now owns 4,087,116 shares of the basic materials company’s stock worth $462,662,000 after buying an additional 1,506,057 shares during the period. Flossbach Von Storch AG raised its stake in Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock worth $462,920,000 after buying an additional 1,034,400 shares during the period. UBS Asset Management Americas Inc. raised its stake in Monsanto by 55.2% in the first quarter. UBS Asset Management Americas Inc. now owns 2,181,090 shares of the basic materials company’s stock worth $246,899,000 after buying an additional 775,520 shares during the period. Finally, MARSHALL WACE ASIA Ltd bought a new stake in Monsanto during the first quarter worth $63,977,000. 75.31% of the stock is owned by institutional investors.
Monsanto Company (MON) traded down 0.33% on Friday, hitting $116.55. The company’s stock had a trading volume of 1,012,471 shares. The firm has a 50 day moving average of $117.47 and a 200 day moving average of $115.08. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97. The firm has a market cap of $51.20 billion, a price-to-earnings ratio of 25.17 and a beta of 1.07.
Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The firm had revenue of $4.23 billion during the quarter, compared to the consensus estimate of $4.18 billion. During the same quarter in the previous year, the firm posted $2.17 earnings per share. The company’s revenue was up 1.0% on a year-over-year basis. Equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Thursday, October 5th. Monsanto’s dividend payout ratio is presently 46.75%.
COPYRIGHT VIOLATION WARNING: This piece of content was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/13/parkwood-llc-buys-5535-shares-of-monsanto-company-nysemon.html.
A number of equities research analysts have recently weighed in on MON shares. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price for the company in a research note on Friday, June 16th. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price for the company in a research note on Thursday, July 6th. Susquehanna Bancshares Inc reissued a “neutral” rating and issued a $128.00 target price (up previously from $125.00) on shares of Monsanto in a research note on Tuesday, June 27th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $128.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $123.15.
In other news, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Janet M. Holloway sold 3,337 shares of Monsanto stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $118.00, for a total transaction of $393,766.00. Following the sale, the senior vice president now directly owns 44,405 shares of the company’s stock, valued at approximately $5,239,790. The disclosure for this sale can be found here. Insiders have sold 74,470 shares of company stock valued at $8,791,281 in the last ninety days. Insiders own 0.79% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.